tradingkey.logo
搜索

Nanobiotix SA

NBTX
添加自选
39.815USD
+0.115+0.29%
收盘 07-24 16:00美东报价延迟15分钟
1.93B总市值
亏损市盈率 TTM

关于 Nanobiotix SA 公司

Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

Nanobiotix SA简介

公司代码NBTX
公司名称Nanobiotix SA
上市日期Oct 29, 2012
CEOLevy (Laurent)
员工数量108
证券类型Depository Receipt
年结日Oct 29
公司地址60 rue de Wattignies
城市PARIS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家France
邮编75012
电话33140260470
网址https://www.nanobiotix.com
公司代码NBTX
上市日期Oct 29, 2012
CEOLevy (Laurent)

Nanobiotix SA公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--

常见问题

Nanobiotix SA的前五大股东是谁?

Nanobiotix SA 的前五大股东如下:Dr. Laurent Levy, Ph.D.

有多少机构持有Nanobiotix SA(NBTX)的股份?

截至2026Q1,共有30家机构持有Nanobiotix SA的股份,合计持有的股份价值约为5.71M,占公司总股份的11.79%。与2025Q4相比,机构持股有所增加,增幅为-3044728.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有